Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21064941 | 0.79 | MAPK1 (0.41) | DNM1TDP1 | |
| SCHEMBL17904930 | 0.79 | MAPK1 (0.41) | DNM1TDP1 | |
| SCHEMBL23159831 | 0.76 | DNM1 (0.43) | DNM1LPAR1LPAR3LPAR2TDP1 | |
| SCHEMBL9750843 | 0.75 | TSHR (0.39) | LPAR1LPAR3LPAR2TDP1ALDH1A1 | |
| SCHEMBL3419031 | 0.74 | TDP1 (0.50) | DNM1LPAR1LPAR3LPAR2TDP1 | |
| SCHEMBL27554399 | 0.74 | DNM1 (0.47) | DNM1LPAR1LPAR3LPAR2SPHK1 | |
| SCHEMBL8024586 | 0.73 | LPAR3 (0.41) | LPAR1LPAR3LPAR2TDP1ALDH1A1 | |
| SCHEMBL20476803 | 0.73 | LPAR3 (0.41) | LPAR1LPAR3LPAR2TDP1ALDH1A1 | |
| SCHEMBL2856530 | 0.73 | LPAR3 (0.41) | LPAR1LPAR3LPAR2TDP1ALDH1A1 | |
| SCHEMBL29690454 | 0.73 | LPAR3 (0.41) | LPAR1LPAR3LPAR2TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167209-A1 | CROSSLINKABLE PREPOLYMERS FOR CHEMICALLY STABLE POLYMER GELS | LUMENDO AG (CH) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167209-A1 | CROSSLINKABLE PREPOLYMERS FOR CHEMICALLY STABLE POLYMER GELS | HPGDS, HPGD, PLOD1 | DNM1 1074/4885LPAR1 3814/4885LPAR3 3667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.